RAB9AP5

Across TCGA pan-cancer cohorts, RAB9AP5 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RAB9AP5 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RAB9AP5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RAB9AP5 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

LIHC and ESCA are the cancer types where RAB9AP5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.144	0.688	.013	27	view →
ESCA	DFS	Tertile	III,IV	1.000	0.281	.043	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RAB9AP5–LIHC (OS)

Open the LIHC breakdown →